Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Analgesics
Research reports on analgesics from Johann Wolfgang Goethe University, Department of Anaesthesiology provide new insights
April 10th, 2007
Scientists discuss in "Epidural ropivacaine -- where are the benefits' A prospective, randomized, double-blind trial in patients with retropubic prostatectomy" new findings in analgesics. According to recent research from Mainz, Germany, "In comparison with bupivacaine, ropivacaine exhibits comparable anaesthetic effects but with less motor impairment and systemic toxicity. However, the analgesic potency may differ." "For example, ropivacaine during obstetric epidural analgesia provides an approximately 40% lower analgesic potency than bupivacaine. Equal visual analogue pain scores require significantly higher dosages of ropivacaine, and general statements about a...
Source: Drug Law Weekly (2007-04-10)
|
